The expression data of 44 cancer types and OS data of corresponding samples were obtained, and higher NR2F6 expression was associated with worse OS in GBMLGG, LGG, SKCM, ALL, MISO, LAML, ACC, ALL-R, and NB, and higher expression of NR2F66 in BLCA was associated with better OS (Fig 2C). This evidence concerns the gene MISO1 and neuroblastoma.